FDA
-
-
-
-
-
-
-
Inspire Medical Systems, Inc. Announces Preliminary Unaudited Revenue Results for the Fourth Quarter and Full Year 2025 and Provides Initial 2026 Revenue Guidance
-
-
-
-
-
-
-
Inspire Medical Systems presents clinical data for new sleep apnea device
-
-
-
-
-
-
-
Inspire Medical Systems authorizes $200 million share buyback program
-
-
-
-
-
-
-
Inspire Medical Systems, Inc. to Present at the BofA Securities 2025 Health Care Conference
-
-
-
-
-
-
-
Inspire Medical Systems (INSP) Reports Prelim Q4
-
-
-
-
-
-
-
Inspire Medical Systems (INSP) Announces $75M Accelerated Share Buyback
-
-
-
-
-
-
-
Inspire Medical Systems (INSP) Announces $150M Share Buyback
-
322,897 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

